5,6-Dihydro-11-methoxyyangonin



Compound IDCDAMM02434
Common name5,6-Dihydro-11-methoxyyangonin
IUPAC name2-[2-(3,4-dimethoxyphenyl)ethenyl]-4-methoxy-2,3-dihydropyran-6-one
Molecular formulaC16H18O5

Experimental data

Retention time5.48
Adduct[M+H]+
Actual mz291.123
Theoretical mz291.122
Error2.49
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.3868

Identifiers and class information

Inchi keyFISBBPCLKKQWQA-XQRVVYSFNA-N
SmilesO=C1OC(C=CC2=CC=C(OC)C(OC)=C2)CC(OC)=C1
SuperclassPhenylpropanoids and polyketides
ClassKavalactones

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)290.315
Computed dipole moment(dipole)7.437
Total solvent accessible surface area (SASA)562.433
Hydrophobic component of SASA (FOSA)342.836
Hydrophilic component of SASA (FISA)69.772
Pie component of the SASA (PISA)149.825
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)964.584
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)5.25
Free energy of solvation of dipole (dip^2/V)0.0573366
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.839436
Predicted polarizability in cubic angstroms (QPpolrz)30.669
Predicted hexadecane/gas partition coefficient (QPlogPC16)8.675
Predicted octanol/gas partition coefficient (QPlogPoct)13.057
Predicted water/gas partition coefficient (QPlogPw)6.635
Predicted octanol/water partition coefficient (QPlogPo/w)2.724
Predicted aqueous solubility (QPlogS)-3.312
Conformation-independent predicted aqueous solubility (CIQPlogS)-3.393
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.845
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)2159
Predicted brain/blood partition coefficient (QPlogBB)-0.398
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)1136.68
Predicted skin permeability, log Kp (QPlogKp)-1.798
PM3 calculated ionization potential (IP(ev))8.745
PM3 calculated electron affinity (EA(eV))0.447
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)-0.198
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)64.292
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P05067APPBeta amyloid A4 proteinT87024SEA
P11926ODC1Ornithine decarboxylaseT60366SEA
P11474ESRRAEstrogen-related receptor alphaT72841SEA
P19838NFKB1Nuclear factor NF-kappa-B p105 subunitT83145SEA
P11388TOP2ADNA topoisomerase II alphaT17048SEA
Q9UNQ0ABCG2ATP-binding cassette sub-family G member 2T56556SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P10636MAPTMicrotubule-associated protein tauT45593SEA
Q04760GLO1Glyoxalase IT88285SEA
P19438TNFRSF1ATumor necrosis factor receptor R1T86552SEA
Q16236NFE2L2Nuclear factor erythroid 2-related factor 2T88505SEA
Q9H4B7TUBB1Tubulin beta-1 chainT84397SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T87024DI0025Alzheimer disease[ICD-11: 8A20]P05067APP
T87024DI0122Diagnostic imaging[ICD-11: N.A.]P05067APP
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T72841DI0366Rheumatoid arthritis[ICD-11: FA20]P11474ESRRA
T83145DI0218Irritable bowel syndrome[ICD-11: DD91]P19838NFKB1
T83145DI0366Rheumatoid arthritis[ICD-11: FA20]P19838NFKB1
T17048DI0012Acute myeloid leukaemia[ICD-11: 2A60]P11388TOP2A
T17048DI0225Kaposi sarcoma[ICD-11: 2B57]P11388TOP2A
T17048DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P11388TOP2A
T56556DI0218Irritable bowel syndrome[ICD-11: DD91]Q9UNQ0ABCG2
T56556DI0366Rheumatoid arthritis[ICD-11: FA20]Q9UNQ0ABCG2
T45593DI0012Acute myeloid leukaemia[ICD-11: 2A60]P10636MAPT
T45593DI0025Alzheimer disease[ICD-11: 8A20]P10636MAPT
T45593DI0265Mild neurocognitive disorder[ICD-11: 6D71]P10636MAPT
T88285DI0210Influenza[ICD-11: 1E30-1E32]Q04760GLO1
T86552DI0060Brain cancer[ICD-11: 2A00]P19438TNFRSF1A
T86552DI0321Ovarian cancer[ICD-11: 2C73]P19438TNFRSF1A
T88505DI0038Ataxic disorder[ICD-11: 8A03]Q16236NFE2L2
T84397DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9H4B7TUBB1

Copyright © 2025